Biosense Webster, Inc.
USPTO PatentsView assignee record - 98 granted patents across 14 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Biosense ranks #3,697 of 49,997 tracked US assignees by granted-patent volume, with 98 patents across 14 technology areas.
- #3,697
- of 49,997 US assignees by volume
- Top 26%
- by Innovation Score (44.1/100)
- 18.6
- avg claims per patent
- -74%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3697 · US Corporation #3,697 · 98 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 98 grants
- TOP-DECILE #3,697/49,997
- PHOTO-FINISH Adient Luxembourg…
- CPC-FOCUS A61B · 14 areas
- INNOV-PAR 44.1/100
- CLAIMS-RICH 18.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -74% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Adient Luxembourg Holding S.a.r.l. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Biosense’s 44.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Biosense
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Biosense Webster · this assignee
Biosense Webster · this assignee
44 score
- HangZhou HaiCun… · near
HangZhou HaiCun… · near
44 score
- Mitac Computing… · near
Mitac Computing… · near
44 score
- Arcturus Therapeutics · near
Arcturus Therapeutics · near
44 score
- PolyOne · near
PolyOne · near
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Biosense's Innovation Score is 44.1/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Biosense?
Each dot is one of Biosense’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biosense’s own 18.6 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Biosense's grants concentrate
Biosense Webster, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 94.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (24 grants) versus a trough of 2 in 2021. By volume, Biosense sits between Veeva Systems Inc. and Flir Systems AB.
Biosense's three-year grant acceleration
From 2019–2021 to 2022–2024, Biosense Webster, Inc. moved from 21 to 12 grants (0.57x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Biosense's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Veeva Systems
Veeva Systems Inc.
99 patents
- Wheel Group Holdi…
Wheel Group Holdings, LLC
99 patents
- Aichi Steel
Aichi Steel Corporation
98 patents
- Adient Luxembourg…
Adient Luxembourg Holding S.a.r.l.
98 patents
- CTS
CTS Corporation
98 patents
- Curevac
CureVac AG
98 patents
- Delta T
Delta T, LLC
98 patents
- Flir Systems AB
Flir Systems AB
98 patents
- Biosense Webster ◀
Biosense Webster, Inc.
98 patents
What this shows Biosense holds 98 patents at rank #3,697, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Biosense
By rank, the assignees closest to #3,697 in granted patent volume.
- Veeva Systems Inc. #3,693 · 99 patents
- Wheel Group Holdings, LLC #3,694 · 99 patents
- Aichi Steel Corporation #3,695 · 98 patents
- Adient Luxembourg Holding S.a.r.l. #3,696 · 98 patents
- CTS Corporation #3,698 · 98 patents
- CureVac AG #3,699 · 98 patents
- Delta T, LLC #3,700 · 98 patents
- Flir Systems AB #3,701 · 98 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Biosense's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Biosense, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Biosense ranks #197 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (44 here).
Similar claim depth
Nearest assignees by average claims per patent (18.6 here).
Biosense's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 24 | 24.5% |
| 2016 | 15 | 15.3% |
| 2017 | 15 | 15.3% |
| 2018 | 11 | 11.2% |
| 2019 | 13 | 13.3% |
| 2020 | 6 | 6.1% |
| 2021 | 2 | 2.0% |
| 2022 | 7 | 7.1% |
| 2024 | 5 | 5.1% |
Which technologies does Biosense Webster, Inc. patent most?
Top 14 of 14 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Biosense Webster, Inc.'s patent record in context - here's where to go next.
- Biosense Webster, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 94.9% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #3,697 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Biosense Webster, Inc. against Veeva Systems Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.